BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15848586)

  • 21. Immunity to varicella zoster virus among young adults: a decline prior to widespread uptake of varicella vaccines.
    Grotto I; Balicer RD; Smetana Z; Davidovitch N; Bar-Zeev Y; Mendelson E; Zarka S; Huerta M
    Infection; 2008 Mar; 36(2):130-4. PubMed ID: 18379727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of varicella-zoster antibodies in pregnant women in Catalonia (Spain). Rationale for varicella vaccination of women of childbearing age.
    Plans P; Costa J; Espuñes J; Plasència A; Salleras L
    BJOG; 2007 Sep; 114(9):1122-7. PubMed ID: 17666097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Live varicella immunization in healthy non-immune nurses.
    Ndumbe PM; Cradock-Watson JE; Heath RB; Levinsky RJ
    Postgrad Med J; 1985; 61 Suppl 4():133-5. PubMed ID: 3014470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Primary varicella-zoster virus infection--current knowledge, diagnostic and therapeutic approaches].
    Cvjetković D; Jovanović J; Hrnjaković-Cvjetković I
    Med Pregl; 2000; 53(5-6):272-6. PubMed ID: 11089369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Varicella-zoster virus-specific cellular immunity in subjects given acyclovir after household chickenpox exposure.
    Kumagai T; Kamada M; Igarashi C; Yuri K; Furukawa H; Chiba S; Kojima H; Saito A; Okui T; Yano S
    J Infect Dis; 1999 Sep; 180(3):834-7. PubMed ID: 10438374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The safety profile of varicella vaccine: a 10-year review.
    Galea SA; Sweet A; Beninger P; Steinberg SP; Larussa PS; Gershon AA; Sharrar RG
    J Infect Dis; 2008 Mar; 197 Suppl 2():S165-9. PubMed ID: 18419392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Administration of live varicella vaccine to HIV-infected children with current or past significant depression of CD4(+) T cells.
    Levin MJ; Gershon AA; Weinberg A; Song LY; Fentin T; Nowak B;
    J Infect Dis; 2006 Jul; 194(2):247-55. PubMed ID: 16779732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chickenpox vaccines: new drugs. A favourable risk-benefit balance in some situations.
    Prescrire Int; 2005 Jun; 14(77):85-91. PubMed ID: 15977369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary varicella after transplantation.
    Scanlon-Kohlroser CA; Fan PY; Primack W; Stoff JS
    Am J Kidney Dis; 2002 Jun; 39(6):1310-2. PubMed ID: 12046047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Varicella zoster virus: vaccination and implications in children with renal failure.
    Fadrowski JJ; Furth SL
    Expert Rev Vaccines; 2004 Jun; 3(3):291-8. PubMed ID: 15176945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunity to varicella zoster virus in young Israeli adults.
    Avrahami-Heller Y; Cohen D; Orr N; Slepon R; Ashkenazi I; Danon YL
    Isr Med Assoc J; 2000 Mar; 2(3):196-9. PubMed ID: 10774265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seroprevalence of Varicella-Zoster virus IgG antibodies in Swiss children during the first 16 months of age.
    Heininger U; Desgrandchamps D; Schaad UB
    Vaccine; 2006 Apr; 24(16):3258-60. PubMed ID: 16459000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Incorporation of varicella-zoster virus vaccination in childhood immunization schedules].
    Rothbart H; Rishpon S
    Harefuah; 2008; 147(8-9):693-7, 751, 750. PubMed ID: 18935757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Protective effect of vaccination against chickenpox].
    Plesník V; Príkazský V; Pĕtvaldská L
    Epidemiol Mikrobiol Imunol; 2000 Nov; 49(4):143-7. PubMed ID: 11188760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Varicella seroepidemiology in United States air force recruits: A retrospective cohort study comparing immunogenicity of varicella vaccination and natural infection.
    Duncan JR; Witkop CT; Webber BJ; Costello AA
    Vaccine; 2017 Apr; 35(18):2351-2357. PubMed ID: 28359621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA sequence analysis of varicella-zoster virus gene 62 from subclinical infections in healthy children immunized with the Oka varicella vaccine.
    Gomi Y; Ozaki T; Nishimura N; Narita A; Suzuki M; Ahn J; Watanabe N; Koyama N; Ushida H; Yasuda N; Nakane K; Funahashi K; Fuke I; Takamizawa A; Ishikawa T; Yamanishi K; Takahashi M
    Vaccine; 2008 Oct; 26(44):5627-32. PubMed ID: 18706951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seroepidemiology of varicella-zoster virus infection in a cosmopolitan city (Erzurum) in the eastern Turkey.
    Alp H; Altinkaynak S; Ertekin V; Kiliçaslan B; Giiraksin A
    Health Policy; 2005 Apr; 72(1):119-24. PubMed ID: 15760704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of shingles by varicella zoster virus vaccination.
    Holodniy M
    Expert Rev Vaccines; 2006 Aug; 5(4):431-43. PubMed ID: 16989624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perspective on live varicella vaccine.
    Gershon AA; Katz SL
    J Infect Dis; 2008 Mar; 197 Suppl 2():S242-5. PubMed ID: 18419404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Varicella zoster virus: natural history and current therapies of varicella and herpes zoster.
    Breuer J; Whitley R
    Herpes; 2007 Sep; 14 Suppl 2():25-9. PubMed ID: 17939892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.